State Street SPDR S&P Biotech ETF (XBI) news
Recent news
Biotech ETFs gain premarket after Moderna's melanoma vaccine with Merck succeeds in large trial
Biotech ETFs gained traction in premarket trading on August 19, 2026, following the announcement that Moderna and Merck’s experimental personalized mRNA cancer vaccine showed positive results in a late-stage trial for melanoma. The regimen, combining Merck’s Keytruda with Moderna’s intismeran,…
AInvest Wire · Aug 19, 2026iShares biotech ETF up 3.2%, State Street SPDR S&P biotech ETF up 2.9%
On August 19, 2026, the iShares Biotechnology ETF (IBB) rose by 3.2%, reflecting continued investor interest in the biotechnology sector. The fund, which tracks the Dow Jones U.S. Biotechnology Index, provides exposure to biotechnology companies . The performance of IBB aligns with broader market…
AInvest Wire · Aug 19, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.